| Thyroid function before, during, and after COVID-19 B Khoo, T Tan, SA Clarke, EG Mills, B Patel, M Modi, M Phylactou, ... The Journal of Clinical Endocrinology & Metabolism 106 (2), e803-e811, 2021 | 254 | 2021 |
| Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial JK Prague, RE Roberts, AN Comninos, S Clarke, CN Jayasena, Z Nash, ... The Lancet 389 (10081), 1809-1820, 2017 | 204 | 2017 |
| Novel Concepts for Inducing Final Oocyte Maturation in In Vitro Fertilization Treatment A Abbara, SA Clarke, WS Dhillo Endocrine reviews 39 (5), 593-628, 2018 | 131 | 2018 |
| Impact of COVID-19 on the Endocrine System: A Mini-review SA Clarke, A Abbara, WS Dhillo Endocrinology 163 (1), bqab203, 2022 | 123 | 2022 |
| Kisspeptin modulates sexual and emotional brain processing in humans AN Comninos, MB Wall, L Demetriou, AJ Shah, SA Clarke, ... The Journal of clinical investigation 127 (2), 709-719, 2017 | 115 | 2017 |
| The effects of kisspeptin on β‐cell function, serum metabolites and appetite in humans C Izzi‐Engbeaya, AN Comninos, SA Clarke, A Jomard, L Yang, S Jones, ... Diabetes, Obesity and Metabolism 20 (12), 2800-2810, 2018 | 110 | 2018 |
| Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders A Abbara, PC Eng, M Phylactou, SA Clarke, R Richardson, CM Sykes, ... The Journal of clinical investigation 130 (12), 6739-6753, 2020 | 86 | 2020 |
| Anti-Müllerian hormone (AMH) in the diagnosis of menstrual disturbance due to polycystic ovarian syndrome A Abbara, PC Eng, M Phylactou, SA Clarke, T Hunjan, R Roberts, ... Frontiers in endocrinology 10, 656, 2019 | 75 | 2019 |
| Normal adrenal and thyroid function in patients who survive COVID-19 infection SA Clarke, M Phylactou, B Patel, EG Mills, B Muzi, C Izzi-Engbeaya, ... The Journal of Clinical Endocrinology & Metabolism 106 (8), 2208-2220, 2021 | 74 | 2021 |
| Follicle size on day of trigger most likely to yield a mature oocyte A Abbara, LN Vuong, VNA Ho, SA Clarke, L Jeffers, AN Comninos, ... Frontiers in endocrinology 9, 193, 2018 | 66 | 2018 |
| Neurokinin 3 receptor antagonism rapidly improves vasomotor symptoms with sustained duration of action JK Prague, RE Roberts, AN Comninos, S Clarke, CN Jayasena, ... Menopause 25 (8), 862-869, 2018 | 65 | 2018 |
| A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial A Abbara, S Clarke, R Islam, JK Prague, AN Comninos, ... Human Reproduction 32 (9), 1915-1924, 2017 | 65 | 2017 |
| Kisspeptin across the human lifespan: evidence from animal studies and beyond SA Clarke, WS Dhillo J Endocrinol 229 (3), R83-98, 2016 | 65 | 2016 |
| Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS) M Phylactou, SA Clarke, B Patel, C Baggaley, CN Jayasena, TW Kelsey, ... Clinical Endocrinology 95 (2), 239-252, 2021 | 56 | 2021 |
| Clinical potential of kisspeptin in reproductive health A Abbara, SA Clarke, WS Dhillo Trends in Molecular Medicine 27 (8), 807-823, 2021 | 42 | 2021 |
| Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment A Abbara, R Islam, SA Clarke, L Jeffers, G Christopoulos, AN Comninos, ... Clinical endocrinology 88 (6), 920-927, 2018 | 42 | 2018 |
| Modulations of human resting brain connectivity by kisspeptin enhance sexual and emotional functions AN Comninos, L Demetriou, MB Wall, AJ Shah, SA Clarke, ... JCI insight 3 (20), 2018 | 34 | 2018 |
| FSH requirements for follicle growth during controlled ovarian stimulation A Abbara, A Patel, T Hunjan, SA Clarke, G Chia, PC Eng, M Phylactou, ... Frontiers in endocrinology 10, 579, 2019 | 32 | 2019 |
| Clinical and biochemical characteristics of patients presenting with pituitary apoplexy A Abbara, S Clarke, PC Eng, J Milburn, D Joshi, AN Comninos, R Ramli, ... Endocrine connections 7 (10), 1058-1066, 2018 | 30 | 2018 |
| Endocrine requirements for oocyte maturation following hCG, GnRH agonist, and kisspeptin during IVF treatment A Abbara, T Hunjan, VNA Ho, SA Clarke, AN Comninos, C Izzi-Engbeaya, ... Frontiers in Endocrinology 11, 537205, 2020 | 26 | 2020 |
